Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 31 | 4 | 29 | 71 | 16 |
| Gross Profit | 31 | 4 | 29 | 71 | 16 |
| Operating Expenses | 5,810 | 4,686 | 4,639 | 4,700 | 5,070 |
| Operating Income | -5,779 | -4,682 | -4,610 | -4,629 | -5,054 |
| Interest Expense | -18 | -116 | 29 | 47 | 29 |
| Other Income | -1,412 | 218 | -17 | 0 | 267 |
| Pre-tax Income | -7,173 | -4,348 | -4,656 | -4,675 | -4,816 |
| Net Income Continuous | -7,173 | -4,348 | -4,656 | -4,675 | -4,816 |
| Net Income | $-7,173 | $-4,348 | $-4,656 | $-4,675 | $-4,816 |
| EPS Basic Total Ops | -1.93 | -1.18 | -1.28 | -1.28 | -1.37 |
| EPS Basic Continuous Ops | -1.93 | -1.18 | -1.28 | -1.29 | -1.37 |
| EPS Diluted Total Ops | -1.93 | -1.18 | -1.28 | -1.28 | -1.37 |
| EPS Diluted Continuous Ops | -1.93 | -1.18 | -1.28 | -1.29 | -1.37 |
| EBITDA(a) | $-5,740 | $-4,650 | $-4,579 | $-4,597 | $-5,028 |